The following pages link to User:Mary Bearkland:
Displayed 50 items.
- Regorafenib plus toripalimab in patients with metastatic colorectal cancer: a phase Ib/II clinical trial and gut microbiome analysis (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 1 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 2 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 1/Signature 1 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 1/Signature 2 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 2/Signature 1 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 2/Signature 2 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 3 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 4 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 5 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 3/Signature 1 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 3/Signature 2 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 4/Signature 1 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 5/Signature 1 (← links)
- A comprehensive analysis of the microbiota composition and host driver gene mutations in colorectal cancer/Experiment 5/Signature 2 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 1 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 1/Signature 1 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 1/Signature 2 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 2 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 2/Signature 1 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 2/Signature 2 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 3 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 3/Signature 1 (← links)
- Effects of prebiotics on immunologic indicators and intestinal microbiota structure in perioperative colorectal cancer patients/Experiment 3/Signature 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 1/Signature 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 1/Signature 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 2/Signature 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 2/Signature 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 3 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 3/Signature 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 3/Signature 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 4 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 4/Signature 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 4/Signature 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 5 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 5/Signature 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 5/Signature 2 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6/Signature 1 (← links)
- Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment/Experiment 6/Signature 2 (← links)
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway (← links)
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 1 (← links)
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 2 (← links)
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 1/Signature 1 (← links)
- Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 1/Signature 2 (← links)
